Sino Medical Sciences Technology Inc. Class ASSE: 688108

Announcement on Voluntary Disclosure of Obtaining EU Approval for Shortening Dual Antiplatelet Therapy Duration to One Month for All Patient Populations Using the Company’s Coronary Stent Products

· Issued by Sino Medical Sciences Technology Inc. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Obtaining EU Approval for Shortening Dual Antiplatelet Therapy Duration to One Month for All Patient Populations Using the Company’s Coronary Stent Products

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis